Literature DB >> 35873068

Reconstruction in Rhino-Orbito-Cerebral Mucormycosis Survivors: A Systematic Review.

Ved Prakash Rao Cheruvu1, Manal M Khan1.   

Abstract

Background: The COVID-19 pandemic has affected the entire world tremendously. Particularly during the second wave in India, a dangerous complication followed in the form of COVID-19-associated mucormycosis. On June 7th, 2021, the Indian Union Health Minister stated that 28,252 cases of mucormycosis were reported from 28 states/Union territories in the country.
Methods: A PubMed search was conducted for English-language studies published from 1988 through May 22, 2021 using the terms "reconstruction AND mucormycosis."
Results: The search yielded 102 results. After excluding the articles not describing reconstruction in mucormycosis, 53 abstracts were screened. Then 34 articles dealing with reconstruction in non-ROC regions were excluded. The full text of 16 articles was reviewed. Additionally, 3 articles were identified from the reference search. Due to the aggressive debridements, rhino-orbito-cerebral mucormycosis survivors may be left with complex tissue defects with significant functional and aesthetic impairments. It is essential to offer reconstructive solutions that improve their quality of life. As far as the timing of reconstruction is concerned, the consensus is in favor of delayed reconstruction after ensuring that the infection has been eliminated/controlled and that there are no recurrences. The most common defects encountered were the ones that resulted from orbital exenteration and excision of a varying extent of the involved contiguous bony and soft tissue structures. Reconstruction with pedicled flaps was preferred rather than free flaps, especially in the cases where the infection was not eliminated completely. Adjuvant antifungal therapy was used in most of the cases. Long-term follow-up was considered essential to detect and treat recurrences. Conclusions: A multitude of options are available for reconstruction in rhino-orbito-cerebral mucormycosis including skin grafts, pedicled flaps, free flaps and in some cases implants and prosthetics. These can be utilized to give as much as functional and aesthetic restoration as possible to the patient.
© 2022, HMP Global. All rights reserved. Reproduction in whole or in part prohibited. Content may not be reproduced in any form without written permission. Rights, Permission, Reprint, and Translation information is available at www.hmpglobal.com.

Entities:  

Keywords:  COVID-19; free tissue flaps; mucormycosis; orbit evisceration; quality of life

Year:  2022        PMID: 35873068      PMCID: PMC9275414     

Source DB:  PubMed          Journal:  Eplasty        ISSN: 1937-5719


  25 in total

1.  Combined mucormycosis and Aspergillosis of the rhinocerebral region.

Authors:  Carmine Alfano; Stefano Chiummariello; Luca A Dessy; Giovanni Bistoni; Nicolò Scuderi
Journal:  In Vivo       Date:  2006 Mar-Apr       Impact factor: 2.155

2.  Invasive fungal infection of the midfacial and orbital complex due to Scedosporium apiospermum and mucormycosis.

Authors:  Jocelyn M Shand; Roxie M Albrecht; Hugh F Burnett; Alan Miyake
Journal:  J Oral Maxillofac Surg       Date:  2004-02       Impact factor: 1.895

3.  Skull vault destruction after rhinocerebral mucormycosis.

Authors:  Stephen Honeybul; David Anthony Morrison
Journal:  World Neurosurg       Date:  2011-12-10       Impact factor: 2.104

4.  Reconstruction of an extensive peri-orbital defect secondary to mucormycosis in a patient with myelodysplasia.

Authors:  Adrian D Murphy; Peter A Williamson; Martin Vesely
Journal:  J Plast Reconstr Aesthet Surg       Date:  2012-12-08       Impact factor: 2.740

5.  Facial Reconstruction of a Mucormycosis Survivor by Free Rectus Abdominis Muscle Flap, Tissue Expansion, and Ocular Prosthesis.

Authors:  Eldad Silberstein; Yuval Krieger; Nir Rosenberg; Alexander Bogdanov-Berezovsky; Yaron Shoham; Oshra Saphier; Vasileios A Pagkalos; Ben-Zion Joshua
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2016 Nov/Dec       Impact factor: 1.746

6.  Mucormycosis of the head and neck: report of five cases with different presentations.

Authors:  David González Ballester; Raúl González-García; Carlos Moreno García; Luis Ruiz-Laza; Florencio Monje Gil
Journal:  J Craniomaxillofac Surg       Date:  2011-11-13       Impact factor: 2.078

7.  Case report. Successful outcome of invasive nasal sinus zygomycosis in a child with relapsed acute lymphoblastic leukaemia due to liposomal amphotericin B.

Authors:  Y A Wali; Z al Lamki; H al Kindi; A M Taqi; W Shah; H Soliman; M Zackaria; H al Okbi
Journal:  Mycoses       Date:  2001       Impact factor: 4.377

Review 8.  Using free flaps for reconstruction during infections by mucormycosis: A case report and a structured review of the literature.

Authors:  C Reinbold; M Derder; M Hivelin; C Ozil; A Al Hindi; L Lantieri
Journal:  Ann Chir Plast Esthet       Date:  2015-06-22       Impact factor: 0.660

9.  Reconstruction of extensive maxillary defects using zygomaticus implants.

Authors:  Brian L Schmidt; M A Pogrel; Carl W Young; Arun Sharma
Journal:  J Oral Maxillofac Surg       Date:  2004-09       Impact factor: 1.895

10.  Rhino-Orbito-Cerebral Mucormycosis: Two Cases with Amaurosis as Presentation, Medical Surgical Management and Follow-Up.

Authors:  Carmen Navarro-Perea; Ignacio Cañas-Zamarra; Enrique Mencía-Gutiérrez; Enrique Revilla-Sánchez; María-Dolores Lago-Llinás; Silvia Pérez-Trigo; Álvaro Bengoa-González
Journal:  Case Rep Ophthalmol Med       Date:  2019-12-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.